2022 International Congress Archives - Page 70 of 153

Grey and white matter brain structural alterations in patients with Essential Tremor plus dystonic soft signs

D. Brinker, O. Granert, I. Tödt, R. Wolke, G. Deuschl, J. Becktepe (Kiel, Germany)
GRIN2D is a cause of autosomal dominant form of Parkinson’s disease

A. Kishore, M. Sturm, J. Shin, S. Grover, F. Raimondi, C. Blauwendraat, S. Robert, G. Sarma, N. Casadei, P. Lichtner, A. Kumar-Sreelatha, J. Winkelmann, R. Krüger, A. Singleton, T. Gasser, P. Seth, J. Roeper, O. Riess, M. Sharma (Kochi, India)
GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase show evidence of pharmacological efficacy in conduritol β-epoxide (CBE) models of Parkinson’s disease

B. Guzman, N. Perez, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, A. Henriques, L. Rouviere, R. Maj (Lugano, Switzerland)
Gut dysbiosis in patients with dementia with Lewy bodies

H. Nishiwaki, M. Ito, T. Hamaguchi, K. Kashihara, T. Maeda, Y. Tsuboi, M. Katsuno, M. Hirayama, K. Ohno (Nagoya, Japan)
HAB-C murine model present reactive adult neurogenesis and astrogliosis in adult brain

V. Hernandez, A. Juarez, D. Carmona (Leon, Mexico)
Has the COVID-19 pandemic had an impact on Functional Movement Disorders phenotype?: experience from a specialized Unit in Spain.

A. López-Jiménez, JD. Guerra-Hiraldo, M. Kurtis, I. Pareés (Madrid, Spain)
Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline

E. Brown, M. San Luciano, S. Goldman, M. Korell, B. Contreras, C. Tanner (San Francisco, USA)
Heart rate variability is affected by standing and medication intake in Parkinson’s disease

F. Cucinotta, F. Morgante, I. Cociasu, E. Pereira, E. Makovac, L. Ricciardi (London, United Kingdom)
Heart-brain synchronization breakdown in Parkinson’s disease

M. Iniguez, A. Jimenez-Marin, A. Erramuzpe, M. Acera, B. Tijero, A. Murueta-Goyena, R. Del Pino, T. Fernandez, M. Carmona‑abellan, A. Cabrera, JC. Gomez‑esteban, J. Cortes, I. Gabilondo (Getafe, Spain)
Height and nigral neuron density in Parkinson’s disease

L. Saari, E. Backman, P. Wahlsten, M. Gardberg, V. Kaasinen (Turku, Finland)